From: Pathophysiological role of calcium channels and transporters in the multiple myeloma
Name | Related channels/transporters | Main localization | Compound | Mechanism | Pathophysiological role in MM | References |
---|---|---|---|---|---|---|
TRPVs | TRPV1 | Plasma membrane | Capsaicin | Activator | TRPV1 inhibitor has synergistic anti-MM activity with bortezomib | [47] |
TRPV2 | Plasma membrane | SKF96365 | Inhibitor | TRPV2 promotes osteoclast differentiation | [13] | |
TRPV4 | Plasma membrane | – | – | TRPV4 activation promotes osteoclast differentiation and bone resorption | [60] | |
TRPMs | TRPM7 | Plasma membrane | – | – | TRPM7 regulates MM cell motility and dissemination | [68] |
GPCRs | CaSR | Plasma membrane | CaCl2 Gadolinium Neomycin | Activator Activator Activator | CaSR promotes the mitosis of MM cells | [57] |
CTR | Plasma membrane | Calcitonin | Activator | CTR inhibits bone resorption by neutralizing OC migration and shape retraction, and may participate in the osteoclast differentiation of MM | [85] [89] | |
PTH-R1 | Plasma membrane | PTHrP | Activator | PTHrP stimulates the secretion of PTH-R1, promotes proliferation of MM cells and the production of osteoclastogenesis factors | [90] [92] | |
Purinergic receptors | P2X7 | Plasma membrane | ATP | Activator | Activation of P2X7 may induce the apoptosis and prevent the proliferation of MM cells | [15] |
SOCE | Stim1 | Plasma membrane, | SKF-96365 DES 2-APB | Inhibitor Inhibitor Inhibitor | Silencing Stim1 reduces cell viability, leading to apoptosis and cell cycle arrest of MM cells, and the high expression of Stim1 affects the clinical outcome of MM. In addition, Stim1 could regulate the motility and dissemination of diffuse large B-cell lymphoma (DLBCL) cells and MM cells | [16] [68] [126] |
 | Endoplasmic reticulum |  |  |  |  | |
Orai1 | Plasma membrane, | SKF-96365 DES 2-APB | Inhibitor Inhibitor Inhibitor | Silencing Orai1 reduces cell viability, leading to apoptosis and cell cycle arrest of MM cells. And Orai1 regulates the motility and dissemination of diffuse large B-cell lymphoma (DLBCL) cells and MM cells | [16] [68] [111] [126] | |
 | Cytosol | AnCoA4 |  |  |  | |
TRPC1 | Plasma membrane | – | – | Knockout of TRPC1 inhibits the death of MM cells | [132] | |
Mitochondrial Ca2+ transporters | VDAC1 | Mitochondrion, Nucleus | – | – | VDAC1 promotes the growth of MM cells, accelerates the development of MM, and affects the prognosis of patients | [17] [144] |
MCU | Mitochondrion | Ruthenium red | Inhibitor | MCU can reduce MM bortezomib resistance and promote MM cell apoptosis | [151] [152] |